The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: a clinical practice guideline (Q38035521)

From Wikidata
Jump to navigation Jump to search
scientific article published on 15 August 2012
edit
Language Label Description Also known as
English
The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: a clinical practice guideline
scientific article published on 15 August 2012

    Statements

    The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: a clinical practice guideline (English)
    0 references
    Heather A Leitch
    Rena Buckstein
    April Shamy
    John M Storring
    15 August 2012
    162-192

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit